Literature DB >> 33813650

Proportion of diabetic retinopathy among diabetics presenting for the first time to a tertiary eye institute in South India.

Manavi D Sindal1, Tejashree Sathe2, Sabyasachi Sengupta3, Divya Yadav2.   

Abstract

PURPOSE: To detect the proportion of diabetic retinopathy (DR) among diabetics visiting a tertiary eye care institute and correlate presenting symptoms to clinical diagnosis.
METHODS: The study recruited 1000 eyes of 1000 diabetics visiting a tertiary eye care institute in South India for the first time. Along with basic demographic data and systemic history, details of presenting complaints and clinical diagnosis were noted.
RESULTS: Data from 956 cases were analyzed. There were 29 (3%) newly diagnosed diabetics and 927 (97%) known diabetics. The commonest reason for the hospital visit was diminution of vision (66%) followed by "visiting for a routine checkup" (22.3%). Diabetic retinopathy was seen in 492 (51.5%), cataract in 161(17%) and refractive error in 240 patients (79.2%). Vision-threatening DR was present in 216 cases (22.59%) and clinically significant macular edema in 73 cases (7.63%) at first presentation itself.
CONCLUSION: The cohort from a tertiary eye care institute has higher proportion of diabetic retinopathy, with vision-threatening DR at presentation. These data emphasize the need for more robust screening for DR, along with population awareness programs.

Entities:  

Keywords:  Cataract; Diabetes mellitus; Diabetic retinopathy; Diminution of vision; Refractive error; Vision-threatening diabetic retinopathy

Year:  2021        PMID: 33813650     DOI: 10.1007/s10792-021-01835-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  1 in total

1.  Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study.

Authors:  Sannapaneni Krishnaiah; Taraprasad Das; Praveen K Nirmalan; Bindiganavale R Shamanna; Rishita Nutheti; Gullapalli N Rao; Ravi Thomas
Journal:  Clin Ophthalmol       Date:  2007-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.